Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Kalinsky

Showing results (21-30 of 151) with videos related to

Pageof 16
Sort By:
Clinical Breast Cancer|November 4, 2022
Racial Disparities in Clinical Outcomes on Investigator-Initiated Breast Cancer Clinical Trials at an Urban Medical CenterJeffrey Aldrich, Princess Ekpo, Manali Rupji, et al.
Breast Cancer Research and Treatment|September 27, 2017
Obesity and survival in the neoadjuvant breast cancer setting: role of tumor subtype in an ethnically diverse populationYing L Liu, Anurag Saraf, Benjamin Catanese, et al.
Clinical Breast Cancer|March 30, 2021
Advances in Therapeutic Approaches for Triple-Negative Breast CancerReshma Mahtani, Muaiad Kittaneh, Kevin Kalinsky, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 22, 2018
Convolutional Neural Network Using a Breast MRI Tumor Dataset Can Predict Oncotype Dx Recurrence ScoreRichard Ha, Peter Chang, Simukayi Mutasa, et al.
Biomedical Optics Express|August 28, 2019
Diffuse optical tomography of the breast: a potential modifiable biomarker of breast cancer risk with neoadjuvant chemotherapyMirella L Altoe, Alessandro Marone, Hyun K Kim, et al.
Breast Cancer Research and Treatment|April 10, 2021
Phase II study of propranolol feasibility with neoadjuvant chemotherapy in patients with newly diagnosed breast cancerMadeleine B Hopson, Shing Lee, Melissa Accordino, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 29, 2026
Sociodemographic Disparities in First-Line Treatment and Outcome Patterns in Women With HR+/HER2- Metastatic Breast CancerGregory A Vidal, Julie Katz, Natalia Sadetsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2012
Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancerDawn L Hershman, Elizabeth T Wilde, Jason D Wright, et al.
Clinical Breast Cancer|October 3, 2017
Expanding the Criteria for Nipple-Sparing Mastectomy in Patients With Poor Prognostic FeaturesPriya Jadeja, Richard Ha, Christine Rohde, et al.
Breast Cancer Research and Treatment|January 27, 2022
Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancerThi Truc Anh Nguyen, Lauren M Postlewait, Chao Zhang, et al.
Pageof 16

Showing results (21-30 of 151) with videos related to

Sort By:
Pageof 16
Clinical Breast Cancer|November 4, 2022
Racial Disparities in Clinical Outcomes on Investigator-Initiated Breast Cancer Clinical Trials at an Urban Medical CenterJeffrey Aldrich, Princess Ekpo, Manali Rupji, et al.
Breast Cancer Research and Treatment|September 27, 2017
Obesity and survival in the neoadjuvant breast cancer setting: role of tumor subtype in an ethnically diverse populationYing L Liu, Anurag Saraf, Benjamin Catanese, et al.
Clinical Breast Cancer|March 30, 2021
Advances in Therapeutic Approaches for Triple-Negative Breast CancerReshma Mahtani, Muaiad Kittaneh, Kevin Kalinsky, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 22, 2018
Convolutional Neural Network Using a Breast MRI Tumor Dataset Can Predict Oncotype Dx Recurrence ScoreRichard Ha, Peter Chang, Simukayi Mutasa, et al.
Biomedical Optics Express|August 28, 2019
Diffuse optical tomography of the breast: a potential modifiable biomarker of breast cancer risk with neoadjuvant chemotherapyMirella L Altoe, Alessandro Marone, Hyun K Kim, et al.
Breast Cancer Research and Treatment|April 10, 2021
Phase II study of propranolol feasibility with neoadjuvant chemotherapy in patients with newly diagnosed breast cancerMadeleine B Hopson, Shing Lee, Melissa Accordino, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 29, 2026
Sociodemographic Disparities in First-Line Treatment and Outcome Patterns in Women With HR+/HER2- Metastatic Breast CancerGregory A Vidal, Julie Katz, Natalia Sadetsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2012
Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancerDawn L Hershman, Elizabeth T Wilde, Jason D Wright, et al.
Clinical Breast Cancer|October 3, 2017
Expanding the Criteria for Nipple-Sparing Mastectomy in Patients With Poor Prognostic FeaturesPriya Jadeja, Richard Ha, Christine Rohde, et al.
Breast Cancer Research and Treatment|January 27, 2022
Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancerThi Truc Anh Nguyen, Lauren M Postlewait, Chao Zhang, et al.
Pageof 16